about
Omega-3 eicosapentaenoic acid decreases CD133 colon cancer stem-like cell marker expression while increasing sensitivity to chemotherapy.Up-regulation of miR-146a increases the sensitivity of non-small cell lung cancer to DDP by downregulating cyclin J.A Phase I clinical and pharmacological study of cis-diamminedichloro(2-methylpyridine) platinum II (AMD473).Impact of the oxaliplatin-5 fluorouracil-folinic acid combination on respective intracellular determinants of drug activity.A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours.Platinum drugs in the treatment of non-small-cell lung cancerMiRNA 17 family regulates cisplatin-resistant and metastasis by targeting TGFbetaR2 in NSCLC.Cisplatin damage: are DNA repair proteins saviors or traitors to the cell?MicroRNA 192 regulates chemo-resistance of lung adenocarcinoma for gemcitabine and cisplatin combined therapy by targeting Bcl-2.MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin.In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer.Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice.Benzyl isothiocyanate inhibits HNSCC cell migration and invasion, and sensitizes HNSCC cells to cisplatin.Liposomes, a promising strategy for clinical application of platinum derivatives.Effects of spectator ligands on the specific recognition of intrastrand platinum-DNA cross-links by high mobility group box and TATA-binding proteins.DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexesMicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4.Bifunctional binding of cisplatin to DNA: why does cisplatin form 1,2-intrastrand cross-links with ag but not with GA?Reaction monitoring of platinum(II) complex--5'-guanosine monophosphate adduct formation by ion exchange liquid chromatography/electrospray ionization mass spectrometry.A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin.
P2860
Q31123584-D47F45D8-14CB-408C-AAAE-C261966FCB9AQ32182056-06DD886F-A38F-4AA3-B8F1-0922507D3C0AQ33347267-E702E952-0D00-43FE-AC99-3932EB4D3525Q34522413-0365EA68-CB44-46D6-B145-AF0199642BFBQ34627989-21E7D555-AB7F-4166-87B8-7633B0849601Q34954760-46A1C91F-5855-4E10-B77E-9C5F1FA22A1EQ35145398-F5BB9A2C-17D8-4FD0-AF2D-5DFA5CD7F3D3Q36149816-40E62E8E-D479-4A3E-AF42-7A4CF9DD2C9CQ36182712-7D5A02F7-1437-4B65-8265-ED9DF48C1F92Q36790395-E9EA2E77-7CCA-4E3D-BEC5-A498E7E80F59Q37352731-CBCFB146-AB1F-4DFE-A823-BD630C8CD71FQ37467770-2B7A6D36-0A38-4918-840D-FA173C3F5682Q37619254-8D9DF0C7-5A78-4DBF-B197-46A33D937162Q38087423-2747A08E-646E-4544-8023-3E5FF9CC8DD8Q38297625-A6D98DA4-AA7B-476A-99A2-1061CAAECF71Q38348382-010F7B26-2404-4092-8526-F24037FC5A46Q38976478-9FCA43FF-4146-4FA8-8331-C7D372C76046Q41258864-FDF95FD7-27A6-4843-80CC-1991A70B87F1Q43688105-6D6AF3DF-D801-4058-B7B8-7F4EACD3C90AQ51723475-F3716C00-60C0-41CA-9623-853A07FB51EB
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
New developments and approaches in the platinum arena.
@ast
New developments and approaches in the platinum arena.
@en
type
label
New developments and approaches in the platinum arena.
@ast
New developments and approaches in the platinum arena.
@en
prefLabel
New developments and approaches in the platinum arena.
@ast
New developments and approaches in the platinum arena.
@en
P1433
P1476
New developments and approaches in the platinum arena.
@en
P2093
P304
29-36; discussion 37-8
P356
10.2165/00003495-200059004-00004
P478
59 Suppl 4
P577
2000-01-01T00:00:00Z
P6179
1014443563